Literature DB >> 10530816

Extended glutamate activates metabotropic receptor types 1, 2 and 4: selective features at mGluR4 binding site.

A S Bessis1, N Jullian, E Coudert, J P Pin, F Acher.   

Abstract

To get an insight into the bioactive conformation of glutamic acid and its topological environment at the mGluR4 binding site, a pharmacophore model was constructed using molecular modeling. Agonists of known activities were used to run the Apex-3D program or to validate the resulting model. An extended glutamate conformer, two selective hydrophilic sites and bulk tolerance regions are disclosed. Selective features of mGluR1, mGluR2 and mGluR4 are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530816     DOI: 10.1016/s0028-3908(99)00096-9

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

1.  Closure of the Venus flytrap module of mGlu8 receptor and the activation process: Insights from mutations converting antagonists into agonists.

Authors:  Anne-Sophie Bessis; Philippe Rondard; Florence Gaven; Isabelle Brabet; Nicolas Triballeau; Laurent Prezeau; Francine Acher; Jean-Philippe Pin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-31       Impact factor: 11.205

2.  Three-dimensional model of the extracellular domain of the type 4a metabotropic glutamate receptor: new insights into the activation process.

Authors:  A S Bessis; H O Bertrand; T Galvez; C De Colle; J P Pin; F Acher
Journal:  Protein Sci       Date:  2000-11       Impact factor: 6.725

3.  Characterization of a metabotropic glutamate receptor in the honeybee (Apis mellifera): implications for memory formation.

Authors:  R Kucharski; C Mitri; Y Grau; R Maleszka
Journal:  Invert Neurosci       Date:  2007-03-20

4.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.